PMR Online access    |   tel. +48 12 340 51 00    |   E-mail: info@pmrcorporate.com
 


 

Global pharma compounding firm to build plant in Malopolskie


2013-01-23



Fagron, a global pharmaceutical compounding group based in the Netherlands, plans to invest about PLN 40m (approx. €9.6m) in a production plant and logistics centre in Trzebinia (Malopolskie voivodship), in a local sub-zone of the Krakow Special Economic Zone, Trzebinia’s mayor Stanislaw Szczurek revealed on 22 January.

The parties have signed a letter of intent and the project is already in the designing stage, Mr. Szczurek said. The investment is expected to create several dozen jobs.

In late 2011 Fagron acquired Pharma Cosmetic, a Krakow-based maker and distributor of ingredients for the pharmaceutical and cosmetics industries and for tailor-made medications compounded at pharmacies.

Fagron is active in 28 countries in Europe, the Americas, Asia and the Pacific, employs 1,500 people and in 2011 generated sales turnover of $300m (€225m).



Browse and search in our archive »


subscribe to PMR RSS NEWS channelsSubscribe to PMR RSS NEWS channels »




Free monthly e-letter containing latest news, analyses and business information on economic situation in Poland, Russia, Bulgaria, Czech Republic, Hungary, Romania, Slovakia, Ukraine, Kazakhstan.
Relevant news
 

Useful links         Privacy Policy
Copyright © 2018 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). With over fourteen years of experience, high international standards in projects and publications, highly skilled multilingual staff and a wide network of co-operating research companies and market experts, PMR is one of the largest companies of its type in the region.